ArticlePigment cell & melanoma research2022

A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.

Pui Ying Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.